Zobrazeno 1 - 10
of 2 326
pro vyhledávání: '"Wechalekar AD"'
Autor:
Bomsztyk J; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Ravichandran S; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK.; University College London Hospital, London, UK., Khwaja J; University College London Hospital, London, UK., Cohen O; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Rauf MU; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Foard D; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Martinez-Naharro A; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Venneri L; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Whelan C; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Fontana M; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Hawkins PN; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Gillmore J; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Lachmann H; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK., Mahmood S; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK.; University College London Hospital, London, UK., Wechalekar AD; National Amyloidosis Centre, University College London, Royal Free Campus, London, UK.; University College London Hospital, London, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 138-145. Date of Electronic Publication: 2024 Jun 05.
Autor:
Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy., Masi A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Patel R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Rauf MU; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Sinigiani G; Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy., Wisniowski B; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Filisetti S; Cardiology University Department, Heart Failure Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.; Faculty of Medicine, University of Milano, Milan, Italy., Currie-Cathey J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., O'Beara S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Kotecha T; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Knight D; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Moon JC; Institute of Cardiovascular Science, University College London, London, United Kingdom.; Barts Heart Centre, West Smithfield, London, United Kingdom., Sinagra G; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-HEART), Trieste, Italy., Virsinskaite R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Gilbertson J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Venneri L; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Lachmann H; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Whelan C; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Ravichandran S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Cohen O; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Manisty C; St Bartholomew's Hospital, London, United Kingdom., Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom., Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2024 Nov 01; Vol. 9 (11), pp. 982-989.
Autor:
Chiaro G; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK., Stancanelli C; Nemo SUD Clinical Centre, University Hospital 'G. Martino', Messina, Italy., Koay S; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK.; Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK., Vichayanrat E; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK., Sander L; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK.; Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland., Ingle GT; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK., McNamara P; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK., Carr AS; Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK., Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Whelan CJ; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Reilly MM; Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK., Mathias CJ; Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK., Iodice V; Autonomic Unit, National Hospital for Neurology and Neurosurgery, UCLH NHS Trust, London, UK. v.iodice@ucl.ac.uk.; Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK. v.iodice@ucl.ac.uk.
Publikováno v:
Clinical autonomic research : official journal of the Clinical Autonomic Research Society [Clin Auton Res] 2024 Jun; Vol. 34 (3), pp. 341-352. Date of Electronic Publication: 2024 May 20.
Autor:
Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Wechalekar AD; Division of Medicine, Faculty of Medical Sciences, University College London and the Royal Free London NHS Foundation Trust, London, UK., Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Shimazaki C; Department of Hematology, Japan Community Health Care Organization, Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, Korea., Ikezoe T; Department of Hematology, Fukushima Medical School, Fukushima, Japan., Min CK; Seoul St. Mary's Hospital, Seoul, Korea., Zhou F; Department of Medicine, Peking University First Hospital, Renal Division, Beijing, China., Cai Z; College of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China., Chen X; Department of Nephrology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China., Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan., Katoh N; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Nagano, Japan., Fujisaki T; Matsuyama Red Cross Hospital, Matsuyama, Japan., Shin HJ; Department of Internal Medicine, Pusan National University Hospital, Busan, South Korea., Tran N; Janssen Research & Development, LLC, Los Angeles, CA, USA., Qin X; Janssen Research & Development, LLC, Spring House, PA, USA., Vasey SY; Janssen Research & Development, LLC, Spring House, PA, USA., Tromp B; Janssen Biologics B.V., Leiden, The Netherlands., Weiss BM; Janssen Research & Development, LLC, Spring House, PA, USA., Comenzo RL; Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Lu J; Collaborative Innovation Center of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China. jin1lu@sina.com.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Apr; Vol. 102 (4), pp. 863-876. Date of Electronic Publication: 2023 Mar 02.
Autor:
Cheng R; Division of Cardiology, University of Washington, Seattle, Washington, USA., Kittleson MM; Cardiology, Cedars Sinai Heart Institute, Los Angeles, California, USA., Wechalekar AD; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK., Alvarez-Cardona J; Cardiology, New York University Grossman School of Medicine, New York, New York, USA., Mitchell JD; Cardiology/IM, Washington University in St Louis, St Louis, Missouri, USA., Scarlatelli Macedo AV; Cardiology, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil., Dutra JPP; Center for Oncological Research (CEPON) and SOS Cardio Hospital in Florianópolis, Santa Catarina, Brazil., Campbell CM; Baylor Scott and White Heart and Vascular Hospital, Baylor University Medical Center, Dallas, Texas, USA., Liu JE; Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Landau HJ; Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Davis MK; Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Morrissey S; Oncology, Barnes Hospital School of Nursing, Saint Louis, Missouri, USA., Casselli S; International Cardio-Oncology Society, Tampa, Florida, USA., Lousada I; Amyloidosis Research Consortium, Newton, Massachusetts, USA., Seabra-Garcez JD; Hospital Primavera, Aracaju, Sergipe, Brazil., Szor RS; Hospital 9 de Julho, São Paulo, Brazil., Ganatra S; Lahey Hospital and Medical Center, Burlington, Massachusetts, USA., Trachtenberg B; Houston Methodist Hospital, Houston, Texas, USA., Maurer MS; Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York, USA., Stockerl-Goldstein K; Oncology, Washington University in St Louis, St Louis, Missouri, USA., Lenihan D; Cardiology, International Cardio-Oncology Society and St Frances Healthcare, Cape Girardeau, Missouri, USA cardio-oncologydoc@protonmail.com.
Publikováno v:
Heart (British Cardiac Society) [Heart] 2024 May 23; Vol. 110 (12), pp. 823-830. Date of Electronic Publication: 2024 May 23.
Autor:
Khwaja J; University College London Hospital, London, UK., Bomsztyk J; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK., Atta M; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Bygrave C; University Hospital of Wales, Wales, UK., Forbes A; Royal Cornwall Hospital NHS Trust, Truro, UK., Durairaj S; Hull University Teaching Hospitals NHS Trust, Hull, UK., Fernandes S; The Dudley Group NHS Foundation Trust, Dudley, UK., Taylor J; Rotherham NHS Foundation Trust, Rotherham, UK., Paterson P; Monklands Hospital, NHS Lanarkshire, Airdrie, UK., Brearton G; Clatterbridge Cancer Centre, Liverpool, UK., Crawley C; Addenbrookes Hospital, Cambridge, UK., Sheehy O; Belfast Health and Social Care Trust, Belfast, UK., Brown R; Manchester University NHS Foundation Trust, Manchester, UK., Soutar R; Glasgow Royal Infirmary Glasgow, Glasgow, UK., Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK., Rydzewski A; The National Institute of Medicine of the Ministry of Interior and Administration, Warsaw, Poland., Jamroziak K; Medical University of Warsaw, Warsaw, Poland., Mahmood S; University College London Hospital, London, UK.; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK., Wechalekar AD; University College London Hospital, London, UK.; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1811-1815. Date of Electronic Publication: 2024 Jan 03.
Autor:
Wechalekar K; Department of Nuclear Medicine, Royal Brompton and Harefield Hospitals, London. Part of Guy's and St. Thomas' Foundation Trust, ., Hutt D; National Amyloidosis Centre, University College London, ., Quigley AM; Nuclear Medicine, Royal Free Hospital, London, ., Whelan C; National Amyloidosis Centre, University College London, ., Chan PS; Nuclear Medicine, Royal Free Hospital, London, ., Hossen L; Department of Nuclear Medicine, Royal Brompton and Harefield Hospitals, London. Part of Guy's and St. Thomas' Foundation Trust, ., Armstrong I; Nuclear Medicine Centre, Manchester University NHS Foundation Trust, Manchester and ., Arumugam P; Nuclear Medicine Centre, Manchester University NHS Foundation Trust, Manchester and ., Moody W; Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Wechalekar AD; National Amyloidosis Centre, University College London, .
Publikováno v:
Nuclear medicine communications [Nucl Med Commun] 2024 Apr 01; Vol. 45 (4), pp. 253-262. Date of Electronic Publication: 2024 Jan 26.
Autor:
Bomsztyk J; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Ravichandran S; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Giles HV; University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; University of Birmingham, Birmingham, United Kingdom., Wright N; The Binding Site, Birmingham, United Kingdom., Berlanga O; The Binding Site, Birmingham, United Kingdom., Khwaja J; University College London Hospital, London, United Kingdom., Mahmood S; National Amyloid Centre, Royal Free Hospital, London, United Kingdom.; University College London Hospital, London, United Kingdom., Wisniowski B; National Amyloid Centre, Royal Free Hospital, London, United Kingdom.; University College London Hospital, London, United Kingdom., Cohen O; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Foard D; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Gilbertson J; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Rauf MU; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Starr N; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Martinez-Naharro A; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Venneri L; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Whelan C; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Fontana M; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Hawkins PN; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Gillmore JD; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Lachmann H; National Amyloid Centre, Royal Free Hospital, London, United Kingdom., Harding S; The Binding Site, Birmingham, United Kingdom., Pratt G; University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; University of Birmingham, Birmingham, United Kingdom., Wechalekar AD; National Amyloid Centre, Royal Free Hospital, London, United Kingdom.; University College London Hospital, London, United Kingdom.
Publikováno v:
Blood [Blood] 2024 Mar 28; Vol. 143 (13), pp. 1259-1268.
Autor:
Hatipoglu S; Cardiology Department, Royal Free London NHS Foundation Trust, Pond Street, London, NW3 2QG, UK. s.hatipoglu@nhs.net.; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK. s.hatipoglu@nhs.net., Wechalekar AD; University College London, London, UK.; Royal Free London NHS Foundation Trust, London, UK., Wechalekar K; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2023 Aug; Vol. 30 (4), pp. 1497-1503. Date of Electronic Publication: 2023 Mar 17.
Autor:
Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Patel RK; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Chacko L; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Karia N; Royal Free Hospital, London, UK., Riefolo M; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy., Rauf MU; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Starr N; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Ganesananthan S; Imperial College London, London, UK., Blakeney I; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Kaza N; Imperial College London, London, UK., Filisetti S; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Bolhuis RE; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Rowczenio D; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Gilbertson J; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Hutt D; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Mahmood S; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Lachmann HJ; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Wechalekar AD; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Kotecha T; Royal Free Hospital, London, UK., Knight DS; Royal Free Hospital, London, UK., Coghlan JG; Royal Free Hospital, London, UK., Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Whelan CJ; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Venneri L; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Hawkins P; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, London, UK., Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2024 Feb; Vol. 26 (2), pp. 383-393. Date of Electronic Publication: 2024 Jan 28.